Transaction DateRecipientSharesTypePriceValue
1st July 2020Matthew K Szot1,701Payment by withholding$2.36$4,014.36
1st July 2020Matthew K Szot1,010Exercise of derivative$0.00
1st July 2020Matthew K Szot1,039Exercise of derivative$0.00
18th June 2020Jamie Bechtel Morrison1,198Exercise of derivative$0.00
18th June 2020Marc Dumont564Exercise of derivative$0.00
18th June 2020Julia Ann Williams423Exercise of derivative$0.00
18th June 2020Delphine Francois Chiavarini846Exercise of derivative$0.00
18th June 2020Matthew K Szot846Exercise of derivative$0.00
20th May 2020Matthew K Szot1,000Open or private purchase$2.04$2,040.00
1st April 2020Matthew K Szot1,039Exercise of derivative$0.00
Senes Tech
Senes Tech logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.


SenesTech's first fertility control product candidate is ContraPest. The company was founded by Loretta P. Mayer and Cheryl A. Dyer in July 2004 and is headquartered in Flagstaff, AZ.


Ticker: SNES
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1680378
Employees: 38
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals